Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Trinity Biotech (TRIB) Interest Expenses (2016 - 2024)

Trinity Biotech's Interest Expenses history spans 16 years, with the latest figure at -$3.4 million for Q4 2024.

  • On a quarterly basis, Interest Expenses fell 44.67% to -$3.4 million in Q4 2024 year-over-year; TTM through Dec 2025 was -$3.4 million, a 47.83% increase, with the full-year FY2025 number at $21.4 million, up 123.61% from a year prior.
  • Interest Expenses hit -$3.4 million in Q4 2024 for Trinity Biotech, down from -$2.8 million in the prior quarter.
  • Over the last five years, Interest Expenses for TRIB hit a ceiling of -$264000.0 in Q1 2024 and a floor of -$12.2 million in Q1 2022.
  • Historically, Interest Expenses has averaged -$2.9 million across 5 years, with a median of -$2.3 million in 2023.
  • Biggest five-year swings in Interest Expenses: crashed 910.08% in 2022 and later skyrocketed 89.65% in 2024.
  • Tracing TRIB's Interest Expenses over 5 years: stood at -$1.2 million in 2020, then plummeted by 145.18% to -$3.0 million in 2021, then rose by 20.56% to -$2.4 million in 2022, then grew by 1.97% to -$2.3 million in 2023, then plummeted by 44.67% to -$3.4 million in 2024.
  • Business Quant data shows Interest Expenses for TRIB at -$3.4 million in Q4 2024, -$2.8 million in Q2 2024, and -$264000.0 in Q1 2024.